CVE-2018-1513

Public Exploit

Description

IBM Sterling B2B Integrator Standard Edition 5.2.0 through 5.2.6 is vulnerable to cross-site scripting. This vulnerability allows users to embed arbitrary JavaScript code in the Web UI thus altering the intended functionality potentially leading to credentials disclosure within a trusted session. IBM X-Force ID: 141551.

Category

5.4
CVSS
Severity: Medium
CVSS 3.0 •
CVSS 2.0 •
EPSS 2.82% Top 15%
Vendor Advisory ibm.com
Affected: IBM Sterling B2B Integrator
Published at:
Updated at:

References

Link Tags
https://exchange.xforce.ibmcloud.com/vulnerabilities/141551 third party advisory vdb entry
http://www.ibm.com/support/docview.wss?uid=ibm10717031 vendor advisory
http://www.securityfocus.com/bid/104910 third party advisory vdb entry
https://www.exploit-db.com/exploits/45190/ third party advisory vdb entry exploit

Frequently Asked Questions

What is the severity of CVE-2018-1513?
CVE-2018-1513 has been scored as a medium severity vulnerability.
How to fix CVE-2018-1513?
To fix CVE-2018-1513, make sure you are using an up-to-date version of the affected component(s) by checking the vendor release notes. As for now, there are no other specific guidelines available.
Is CVE-2018-1513 being actively exploited in the wild?
It is possible that CVE-2018-1513 is being exploited or will be exploited in a near future based on public information. According to its EPSS score, there is a ~3% probability that this vulnerability will be exploited by malicious actors in the next 30 days.
What software or system is affected by CVE-2018-1513?
CVE-2018-1513 affects IBM Sterling B2B Integrator.
This platform uses data from the NIST NVD, MITRE CVE, MITRE CWE, First.org and CISA KEV but is not endorsed or certified by these entities. CVE is a registred trademark of the MITRE Corporation and the authoritative source of CVE content is MITRE's CVE web site. CWE is a registred trademark of the MITRE Corporation and the authoritative source of CWE content is MITRE's CWE web site.
© 2025 Under My Watch. All Rights Reserved.